Matthew A Singer, APNP | |
407 9th Ave, Grafton, WI 53024-1155 | |
(262) 370-0212 | |
Not Available |
Full Name | Matthew A Singer |
---|---|
Gender | Male |
Speciality | Clinical Nurse Specialist - Adult Health |
Location | 407 9th Ave, Grafton, Wisconsin |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1033549423 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
364SA2200X | Clinical Nurse Specialist - Adult Health | 5605-33 (Wisconsin) | Primary |
Mailing Address | Practice Location Address |
---|---|
Matthew A Singer, APNP 407 9th Ave, Grafton, WI 53024-1155 Ph: (262) 370-0212 | Matthew A Singer, APNP 407 9th Ave, Grafton, WI 53024-1155 Ph: (262) 370-0212 |
News Archive
The U.S. Food and Drug Administration today announced that monthly liver enzyme tests are no longer required for those taking Letairis tablets (ambrisentan), used to treat high blood pressure in the vessels that carry blood to the lungs (pulmonary arterial hypertension, or PAH).
The new health care law is injecting more competition into health insurance markets nationwide, drawing additional insurance companies into states long dominated by a few carriers, Obama administration officials said Thursday. Such competition offers the prospect of more choices for millions of consumers who will be shopping for insurance this fall. Companies entering the market could also put downward pressure on prices, partly offsetting factors that tend to increase premiums (Pear, 5/30).
Today from the Capsules blog: Mary Agnes Carey reports that former House Energy and Commerce Committee Chairman Billy Tauzin has some advice for Republicans who want Medicare beneficiaries to pick up part of the tab for home health services: It won't work.
NPR reports that 46 million represents "roughly 15 percent of the U.S. population," and the number comes from 2007 Census Bureau estimates. "Although the number of uninsured has grown slowly in the past several years, it's speeding up, mainly because employment has declined drastically since the Census report. And most of us get our insurance through our jobs."
Oceana Therapeutics and Q-Med AB today announced the filing of a Premarket Approval (PMA) application with the U.S. Food and Drug Administration (FDA) for Solesta® for the treatment of Fecal (or Bowel) Incontinence, a largely unsatisfied medical need afflicting millions of Americans.
› Verified 9 days ago
Laura Mckinnis, N.P. Clinical Nurse Specialist Medicare: Medicare Enrolled Practice Location: 1505 Wisconsin Ave Ste 150, Grafton, WI 53024 Phone: 262-421-8961 |